Tokyo, June 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058128) titled 'A clinical performance study to evaluate the utility of QA Commons in patients with advanced solid tumors undergoing comprehensive genomic profiling' on June 9.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center Hospital East
Condition:
Condition - Solid tumor
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - This study aims to evaluate the clinical performance of the AI-based treatment decision support program QA Commons by assessing the concordance between its treatment recommendations and consensus annotations provided by an academ...